Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
10X Genomics Inc
F:1KJ
10X Genomics Inc
F:1KJ
Price:
73.89
EUR
2.97%
Market Closed
Market Cap:
€7.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
10X Genomics Inc
F:1KJ
|
US |
|
H
|
Haverty Furniture Companies Inc
F:25F
|
US |
|
OMV AG
F:OMVI
|
AT |
|
I
|
Intesa Sanpaolo SpA
DUS:IES
|
IT |
|
C
|
Coca-Cola Co
F:CCC3
|
US |
|
W
|
Wheaton Precious Metals Corp
LSE:WPM
|
CA |
|
Stellantis NV
F:8TI
|
NL |
|
NTPC Ltd
NSE:NTPC
|
IN |
Wall St Price Targets
1KJ Price Forecast
Based on 18 analysts
Based on 18 analysts
-89% Downside
from
€73.89
today
10X Genomics Inc (1KJ)’s 12-month stock price forecast through September 2027 has a consensus target of €8.36, implying 89% downside. The forecast is based on price targets from 18 Wall Street analysts.
1KJ Analyst Rating
No ratings yet
No ratings yet
10X Genomics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1KJ's stock price target?
Price Target
8.36
EUR
8.36
EUR
According to Wall Street analysts, the average 1-year price target for 1KJ is 8.36 EUR with a low forecast of 6.62 EUR and a high forecast of 12.05 EUR.
What is the Revenue forecast for 10X Genomics Inc?
Projected CAGR
10%
10%
Over the last 7 years, the compound annual growth rate for Revenue has been 24%. The projected CAGR for the next 8 years is 10%.
What is the Gross Profit forecast for 10X Genomics Inc?
Projected CAGR
10%
10%
Over the last 7 years, the compound annual growth rate for Gross Profit has been 21%. The projected CAGR for the next 8 years is 10%.